Conference: 27 – 29 January 2021 Location: Berlin, Germany / also Live Stream & On- Demand Website: https://bit.ly/2FPoI56 With increased impact from the pandemic, pharma and biotech companies are under
Workshop: 29 – 30 October 2020 Location: Online Virtual Event Website: https://bit.ly/37nZ96x DIA’s mission – to work across the healthcare continuum to ensure patients receive the therapies they need –
Conference: 10 – 11 February 2021 Location: Online Virtual Event Website: https://www.smi-online.co.uk/pharmaceuticals/uk/conference/rna-therapeutics RNA therapeutics is a rapidly expanding industry with increasingly growing potential for immunotherapy personalised medicines, and treatment of
Conference: September 27th - 28th, 2021 (Porto, Portugal) Location: Alfandega Congress Center, R. Nova da Alfândega, 4050-430, Porto, Portugal Website: https://biotechpharmasummit.com The BioTech Pharma Summit will bring together the
Conference: 28 – 29 October 2020 Workshops: 30 October 2020 Location: Virtual Conference: Online Access Only Website: http://www.microbiologyeastcoast.com/farmavitaWB Exploring the current approaches towards improved contamination control The pharmaceutical microbiology industry
Conference: 22 – 23 November 2021 Venue: London, UK Website: www.ophthalmicdrugs.com/farmavitawl Exploring the future of ocular drug development 4th Annual Ophthalmic Drugs Conference taking place on the 22nd and 23rd
On October 27-29, 2020 the XI International Exhibition of Equipment and Technologies for the Pharmaceutical Industry PHARMATechExpo will be held at the ACCO International Exhibition Center. This is the only
Are you aware of new European Nitrosamine Regulations - EMA/511347/2019. There is serious workload expected from all marketing authorisation holders (MAH) in EU! Let’s see what is expected for MAH
What is a biological medicinal product? A biological medicinal product is a medicinal product that contains an active substance produced or excreted from biological sources (human, animal, or microbiological). Due
In August 2017, the Brazilian Health Surveillance Agency (ANVISA) published Resolution No. 168/2017, which establishes the administrative procedures related to ANVISA´s “prior consent” for the granting of pharmaceutical patent applications,
